Rheumatoid Arthritis Trial, Recruiting NCT07222696 Sponsor: Weill Medical College of Cornell University Condition: Rheumatoid Arthritis
Back to Rheumatoid Arthritis

Rheumatoid Arthritis Trial, Recruiting

NCT07222696
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Adults aged 18 or older (male or female)
  • People who have been diagnosed with Rheumatoid Arthritis by a specialist doctor (rheumatologist) and are currently taking medication to manage the disease (either a standard or biological type of disease-modifying drug)
  • People who have moderate-to-high levels of depression, measured by a score between 10 and 20 on a standard questionnaire called the PHQ-8, OR high levels of anxiety measured by a score above 10 on a questionnaire called the GAD-7
  • People who speak English or Spanish
  • People who have access to the internet, a computer, and/or a smartphone
  • People who live in any US state, including Puerto Rico
  • People who are willing to work with a peer coach or coach as part of the trial

Who may not be able to join:

  • People who have a rheumatic disease other than Rheumatoid Arthritis, such as psoriatic arthritis, gout, or lupus
  • People who live in a nursing home
  • People who have a history of dementia or significant memory or thinking problems
  • People who are currently confined to bed and unable to get up
  • People with severe depression, defined as a score above 20 on the PHQ-8 questionnaire

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Iris Y Navarro-Millán, MD, Weill Medical College of Cornell University

Phone: 205-529-2978

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
12 January 2026
Est. completion
1 December 2030

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Change from Baseline in Mean Scores in PHQ-8 at 6 months post intervention; Difference in Mean Scores in PHQ-8 Between the Experimental Arm and the Active Control Arm at 6 Months Post Intervention; Change from Baseline in Mean Scores in GAD-7 at 6 months post intervention; Difference in Mean Scores in GAD-7 Between the Experimental Arm and the Active Control Arm at 6 Months Post Intervention

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov